CDC presents preliminary data showing an increase in meningococcal disease among human immunodeficiency virus (HIV)-infected individuals.
J&J’s Megadyne restricts use of electrodes over burn risk, triggering Class I FDA notice
Dive Brief: The Food and Drug Administration has categorized an urgent medical device correction from Johnson & Johnson’s Megadyne as a Class I event. Megadyne